Live from CPHI Milan 2024, this episode is a roundup of conversations with a number of key exhibitors Recipharm, Tjoapack, Renaissance Lakewood, Ecolab and NovaCina.

As you'll hear, it was a noisy event, so written transcripts are all available on PharmaSource.

• Jon Reed, Head of Strategic Business Planning at Recipharm discussed the CDMO’s recent strategic moves, including Predictive Modeling and GLP-1 focus. https://pharmasource.global/content/podcast/recipharms-strategic-moves-embracing-predictive-modeling-and-glp-1-trends/

• Dexter Tjoa, CEO of Tjoapack, shared insights into the company’s 35 year evolution from a small Dutch contract packaging organisation (CPO) to a global player in pharmaceutical packaging.
  https://pharmasource.global/content/podcast/tjoapacks-global-expansion-bridging-european-and-us-pharmaceutical-packaging-markets/

• Eric Kaneps, Vice President of Sales & Marketing at Renaissance Lakewood, discussed the company’s expansion and focus on nasal spray technology. https://pharmasource.global/content/podcast/renaissance-lakewood-drives-cdmo-innovation-in-nasal-spray-technology/

• Craig Cox, Vice President of Global Sales, Bioprocessing at Ecolab, shared insights into the company’s bioprocessing solutions, and how they help support sustainability. https://pharmasource.global/content/podcast/ecolabs-bioprocessing-solutions-addressing-sustainability-and-complexity-in-drug-manufacturing/

• Peter Bullard, Senior Vice President of Manufacturing at NovaCina, shared insights into the new Australian CDMO’s unique position in the global pharmaceutical market and 50 year legacy. https://pharmasource.global/content/podcast/novacina-new-australian-cdmo-with-50-year-legacy-in-sterile-manufacturing/